{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:41:24Z","timestamp":1794962484100,"version":"4.9.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572342"],"award-info":[{"award-number":["81572342"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370945"],"award-info":[{"award-number":["81370945"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570871"],"award-info":[{"award-number":["81570871"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572409"],"award-info":[{"award-number":["81572409"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2014A030313073"],"award-info":[{"award-number":["2014A030313073"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2015A030313029"],"award-info":[{"award-number":["2015A030313029"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2016A030311035"],"award-info":[{"award-number":["2016A030311035"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2015A030313103"],"award-info":[{"award-number":["2015A030313103"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Science and Technology Department","doi-asserted-by":"publisher","award":["2017A020215075"],"award-info":[{"award-number":["2017A020215075"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for Central Universities of the Central South University","doi-asserted-by":"publisher","award":["13ykpy06"],"award-info":[{"award-number":["13ykpy06"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["16ykpy2"],"award-info":[{"award-number":["16ykpy2"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Neuroblastoma (NB) is one of the deadliest paediatric solid tumours due to its rapid proliferative characteristics. Amplified copies of MYCN are considered the most important marker for the prediction of tumour relapse and progression in NB, but they were only detected in 20\u201330% of NB patients, indicating there might be other oncogenes in the development of NB. The far upstream element binding protein 1 (FUBP1) was first identified as a transcriptional regulator of the proto-oncogene MYC. However, the expression and role of FUBP1 in NB have not been documented.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>FUBP1 expression was analysed from GEO database and verified by immunohistochemistry (IHC) and western blotting (WB) in NB tissues and cell lines. Cell proliferation and apoptosis were detected by Cell Counting Kit-8, Colony formation assay, EDU, TUNEL staining and flow cytometric analysis. Several glycolytic metabolites production was confirmed by ELISA and oxygen consuming rate (OCR). Luciferase assay, WB, chromatin immunoprecipitation (CHIP) were used to explore the mechanisms of the effect of FUBP1 on NB.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>FUBP1 mRNA levels were increased along with the increase in International Neuroblastoma Staging System (INSS) stages. High expression of FUBP1 with low N-Myc expression accounted for 44.6% of NB patient samples (<jats:italic>n<\/jats:italic>\u2009=\u200965). In addition, FUBP1 protein levels were remarkably increased with NB malignancy in the NB tissue microarray (NB: n\u2009=\u200965; ganglioneuroblastoma:<jats:italic>n<\/jats:italic>\u2009=\u200931; ganglioneuroma:<jats:italic>n<\/jats:italic>\u2009=\u200927). Furthermore, FUBP1 expression was negatively correlated with patient survival rate but positively correlated with ki67 content. In vitro experiments showed that FUBP1 promotes NB cell proliferation and inhibits cell apoptosis via enhancing glycolysis and ATP production. Mechanistically, FUBP1 inhibited the degradation of HIF1\u03b1 via downregulation of Von Hippel-Lindau (VHL), the E3 ligase for HIF1\u03b1, resulting in upregulation of lactate dehydrogenase isoform B (LDHB) expression to enhance glycolysis. Overexpressed or silenced N-Myc could not regulate FUBP1 or LDHB levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Taken together, our findings demonstrate for the first time that elevated FUBP1 promotes NB glycolysis and growth by targeting HIF1\u03b1 rather than N-Myc, suggesting that FUBP1 is a novel and powerful oncogene in the development of NB independent of N-Myc and may have potential in the diagnosis and treatment of NB.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13046-019-1414-6","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T06:52:46Z","timestamp":1568184766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma"],"prefix":"10.1186","volume":"38","author":[{"given":"Ping","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyou","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanghua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ti","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoquan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,11]]},"reference":[{"key":"1414_CR1","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1200\/JCO.2014.59.4648","volume":"33","author":"NR Pinto","year":"2015","unstructured":"Pinto NR, et al. Advances in risk classification and treatment strategies for neuroblastoma. J Clin Oncol. 2015;33:3008\u201317. https:\/\/doi.org\/10.1200\/JCO.2014.59.4648 .","journal-title":"J Clin Oncol"},{"key":"1414_CR2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7","volume":"86","author":"H Shimada","year":"1999","unstructured":"Shimada H, et al. The international neuroblastoma pathology classification (the Shimada system). Cancer. 1999;86:364\u201372.","journal-title":"Cancer"},{"key":"1414_CR3","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00383-017-4100-9","volume":"33","author":"T Yang","year":"2017","unstructured":"Yang T, et al. Surgical management and outcomes of ganglioneuroma and ganglioneuroblastoma-intermixed. Pediatr Surg Int. 2017;33:955\u20139. https:\/\/doi.org\/10.1007\/s00383-017-4100-9 .","journal-title":"Pediatr Surg Int"},{"key":"1414_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1054\/bjoc.2001.1849","volume":"85","author":"J Mora","year":"2001","unstructured":"Mora J, Cheung NK, Gerald WL. Genetic heterogeneity and clonal evolution in neuroblastoma. Br J Cancer. 2001;85:182\u20139. https:\/\/doi.org\/10.1054\/bjoc.2001.1849 .","journal-title":"Br J Cancer"},{"key":"1414_CR5","doi-asserted-by":"publisher","first-page":"a014415","DOI":"10.1101\/cshperspect.a014415","volume":"3","author":"M Huang","year":"2013","unstructured":"Huang M, Weiss WA. Neuroblastoma and MYCN. Cold Spring Harb Perspect Med. 2013;3:a014415. https:\/\/doi.org\/10.1101\/cshperspect.a014415 .","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1414_CR6","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1242\/dev.124.10.1953","volume":"124","author":"Y Wakamatsu","year":"1997","unstructured":"Wakamatsu Y, Watanabe Y, Nakamura H, Kondoh H. Regulation of the neural crest cell fate by N-myc: promotion of ventral migration and neuronal differentiation. Development. 1997;124:1953\u201362.","journal-title":"Development"},{"key":"1414_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrc1014","volume":"3","author":"GM Brodeur","year":"2003","unstructured":"Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3:203\u201316. https:\/\/doi.org\/10.1038\/nrc1014 .","journal-title":"Nat Rev Cancer"},{"key":"1414_CR8","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S1470-2045(03)01166-5","volume":"4","author":"M Schwab","year":"2003","unstructured":"Schwab M, Westermann F, Hero B, Berthold F. Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol. 2003;4:472\u201380.","journal-title":"Lancet Oncol"},{"key":"1414_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.molonc.2015.09.010","volume":"10","author":"C Masserot","year":"2016","unstructured":"Masserot C, et al. WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastoma. Mol Oncol. 2016;10:240\u201352. https:\/\/doi.org\/10.1016\/j.molonc.2015.09.010 .","journal-title":"Mol Oncol"},{"key":"1414_CR10","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/hep.23051","volume":"50","author":"M Malz","year":"2009","unstructured":"Malz M, et al. Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells. Hepatology. 2009;50:1130\u20139. https:\/\/doi.org\/10.1002\/hep.23051 .","journal-title":"Hepatology"},{"issue":"9","key":"1414_CR11","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/s41379-018-0051-5","volume":"31","author":"Xiao-tong Wang","year":"2018","unstructured":"Wang XT, et al. RNA sequencing of Xp11 translocation-associated cancers reveals novel gene fusions and distinctive clinicopathologic correlations. Mod Pathol. 2018. https:\/\/doi.org\/10.1038\/s41379-018-0051-5 .","journal-title":"Modern Pathology"},{"key":"1414_CR12","doi-asserted-by":"publisher","first-page":"6189","DOI":"10.1038\/onc.2016.151","volume":"35","author":"L Venturutti","year":"2016","unstructured":"Venturutti L, et al. MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1. Oncogene. 2016;35:6189\u2013202. https:\/\/doi.org\/10.1038\/onc.2016.151 .","journal-title":"Oncogene"},{"key":"1414_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bcp.2017.10.003","volume":"146","author":"S Khageh Hosseini","year":"2017","unstructured":"Khageh Hosseini S, et al. Camptothecin and its analog SN-38, the active metabolite of irinotecan, inhibit binding of the transcriptional regulator and oncoprotein FUBP1 to its DNA target sequence FUSE. Biochem Pharmacol. 2017;146:53\u201362. https:\/\/doi.org\/10.1016\/j.bcp.2017.10.003 .","journal-title":"Biochem Pharmacol"},{"key":"1414_CR14","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1158\/0008-5472.CAN-08-3338","volume":"69","author":"S Singer","year":"2009","unstructured":"Singer S, et al. Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer. Cancer Res. 2009;69:2234\u201343. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-3338 .","journal-title":"Cancer Res"},{"key":"1414_CR15","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/4151051a","volume":"415","author":"DT Braddock","year":"2002","unstructured":"Braddock DT, Louis JM, Baber JL, Levens D, Clore GM. Structure and dynamics of KH domains from FBP bound to single-stranded DNA. Nature. 2002;415:1051\u20136. https:\/\/doi.org\/10.1038\/4151051a .","journal-title":"Nature"},{"key":"1414_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1101\/gad.8.4.465","volume":"8","author":"R Duncan","year":"1994","unstructured":"Duncan R, et al. A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. Genes Dev. 1994;8:465\u201380.","journal-title":"Genes Dev"},{"key":"1414_CR17","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/emboj.2011.11","volume":"30","author":"J Liu","year":"2011","unstructured":"Liu J, et al. JTV1 co-activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress. EMBO J. 2011;30:846\u201358. https:\/\/doi.org\/10.1038\/emboj.2011.11 .","journal-title":"EMBO J"},{"key":"1414_CR18","doi-asserted-by":"publisher","unstructured":"Wang, J. et al. A novel long intergenic noncoding RNA indispensable for the cleavage of mouse two-cell embryos. EMBO Rep 17, 1452\u20131470, doi: https:\/\/doi.org\/10.15252\/embr.201642051 (2016).","DOI":"10.15252\/embr.201642051"},{"key":"1414_CR19","doi-asserted-by":"publisher","first-page":"6774","DOI":"10.1038\/onc.2017.286","volume":"36","author":"Y Sun","year":"2017","unstructured":"Sun Y, et al. The long noncoding RNA SNHG1 promotes tumor growth through regulating transcription of both local and distal genes. Oncogene. 2017;36:6774\u201383. https:\/\/doi.org\/10.1038\/onc.2017.286 .","journal-title":"Oncogene"},{"key":"1414_CR20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1158\/1078-0432.CCR-17-0352","volume":"24","author":"Q Zhong","year":"2018","unstructured":"Zhong Q, et al. The RARS-MAD1L1 fusion gene induces Cancer stem cell-like properties and therapeutic resistance in nasopharyngeal carcinoma. Clin Cancer Res. 2018;24:659\u201373. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0352 .","journal-title":"Clin Cancer Res"},{"key":"1414_CR21","first-page":"916","volume":"60","author":"S Walenta","year":"2000","unstructured":"Walenta S, et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 2000;60:916\u201321.","journal-title":"Cancer Res"},{"key":"1414_CR22","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4:891\u20139. https:\/\/doi.org\/10.1038\/nrc1478 .","journal-title":"Nat Rev Cancer"},{"key":"1414_CR23","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/nrc2231","volume":"8","author":"N Meyer","year":"2008","unstructured":"Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer. 2008;8:976\u201390. https:\/\/doi.org\/10.1038\/nrc2231 .","journal-title":"Nat Rev Cancer"},{"key":"1414_CR24","doi-asserted-by":"publisher","first-page":"20491","DOI":"10.1073\/pnas.1206530109","volume":"109","author":"EC Cheung","year":"2012","unstructured":"Cheung EC, Ludwig RL, Vousden KH. Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death. Proc Natl Acad Sci U S A. 2012;109:20491\u20136. https:\/\/doi.org\/10.1073\/pnas.1206530109 .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1414_CR25","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1158\/0008-5472.CAN-16-0401","volume":"76","author":"G Grandjean","year":"2016","unstructured":"Grandjean G, et al. Definition of a novel feed-forward mechanism for glycolysis-HIF1alpha signaling in hypoxic tumors highlights aldolase a as a therapeutic target. Cancer Res. 2016;76:4259\u201369. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0401 .","journal-title":"Cancer Res"},{"key":"1414_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1073\/pnas.1311249111","volume":"111","author":"HJ Wang","year":"2014","unstructured":"Wang HJ, et al. JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1alpha-mediated glucose metabolism. Proc Natl Acad Sci U S A. 2014;111:279\u201384. https:\/\/doi.org\/10.1073\/pnas.1311249111 .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1414_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cmet.2015.07.016","volume":"22","author":"AL Harris","year":"2015","unstructured":"Harris AL. A new Hydroxy metabolite of 2-Oxoglutarate regulates metabolism in hypoxia. Cell Metab. 2015;22:198\u2013200. https:\/\/doi.org\/10.1016\/j.cmet.2015.07.016 .","journal-title":"Cell Metab"},{"key":"1414_CR28","doi-asserted-by":"publisher","first-page":"7277","DOI":"10.1158\/0008-5472.CAN-13-1868","volume":"73","author":"KK Velpula","year":"2013","unstructured":"Velpula KK, Bhasin A, Asuthkar S, Tsung AJ. Combined targeting of PDK1 and EGFR triggers regression of glioblastoma by reversing the Warburg effect. Cancer Res. 2013;73:7277\u201389. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-1868 .","journal-title":"Cancer Res"},{"key":"1414_CR29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ccr.2007.07.006","volume":"12","author":"JD Gordan","year":"2007","unstructured":"Gordan JD, Thompson CB, Simon MC. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell. 2007;12:108\u201313. https:\/\/doi.org\/10.1016\/j.ccr.2007.07.006 .","journal-title":"Cancer Cell"},{"key":"1414_CR30","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1016\/j.bbamcr.2016.07.007","volume":"1863","author":"XW Lin","year":"2016","unstructured":"Lin XW, Tang L, Yang J, Xu WH. HIF-1 regulates insect lifespan extension by inhibiting c-Myc-TFAM signaling and mitochondrial biogenesis. Biochim Biophys Acta. 2016;1863:2594\u2013603. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.07.007 .","journal-title":"Biochim Biophys Acta"},{"key":"1414_CR31","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.7150\/thno.20861","volume":"7","author":"ET Oh","year":"2017","unstructured":"Oh ET, Kim CW, Kim HG, Lee JS, Park HJ. Brusatol-mediated inhibition of c-Myc increases HIF-1alpha degradation and causes cell death in colorectal Cancer under hypoxia. Theranostics. 2017;7:3415\u201331. https:\/\/doi.org\/10.7150\/thno.20861 .","journal-title":"Theranostics"},{"key":"1414_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.bbrc.2012.12.006","volume":"430","author":"C Chen","year":"2013","unstructured":"Chen C, et al. C-Myc enhances colon cancer cell-mediated angiogenesis through the regulation of HIF-1alpha. Biochem Biophys Res Commun. 2013;430:505\u201311. https:\/\/doi.org\/10.1016\/j.bbrc.2012.12.006 .","journal-title":"Biochem Biophys Res Commun"},{"key":"1414_CR33","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ccr.2012.09.021","volume":"22","author":"G Qing","year":"2012","unstructured":"Qing G, et al. ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation. Cancer Cell. 2012;22:631\u201344. https:\/\/doi.org\/10.1016\/j.ccr.2012.09.021 .","journal-title":"Cancer Cell"},{"key":"1414_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/ALN.0b013e318201dcb3","volume":"114","author":"BP Lemkuil","year":"2011","unstructured":"Lemkuil BP, et al. Isoflurane neurotoxicity is mediated by p75NTR-RhoA activation and actin depolymerization. Anesthesiology. 2011;114:49\u201357. https:\/\/doi.org\/10.1097\/ALN.0b013e318201dcb3 .","journal-title":"Anesthesiology"},{"key":"1414_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.114","volume":"8","author":"T Zhang","year":"2017","unstructured":"Zhang T, et al. Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial-mesenchymal transition and metastasis. Cell Death Dis. 2017;8:e2838. https:\/\/doi.org\/10.1038\/cddis.2017.114 .","journal-title":"Cell Death Dis"},{"key":"1414_CR36","doi-asserted-by":"publisher","first-page":"5772","DOI":"10.1158\/1078-0432.CCR-17-2578","volume":"24","author":"C Dorneburg","year":"2018","unstructured":"Dorneburg C, et al. LDHA in neuroblastoma is associated with poor outcome and its depletion decreases neuroblastoma growth independent of aerobic glycolysis. Clin Cancer Res. 2018;24:5772\u201383. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-2578 .","journal-title":"Clin Cancer Res"},{"key":"1414_CR37","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1021\/pr900701v","volume":"9","author":"QR Chen","year":"2010","unstructured":"Chen QR, et al. Global genomic and proteomic analysis identifies biological pathways related to high-risk neuroblastoma. J Proteome Res. 2010;9:373\u201382. https:\/\/doi.org\/10.1021\/pr900701v .","journal-title":"J Proteome Res"},{"key":"1414_CR38","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.immuni.2015.05.016","volume":"42","author":"JH Lee","year":"2015","unstructured":"Lee JH, Elly C, Park Y, Liu YC. E3 ubiquitin ligase VHL regulates hypoxia-inducible factor-1alpha to maintain regulatory T cell stability and suppressive capacity. Immunity. 2015;42:1062\u201374. https:\/\/doi.org\/10.1016\/j.immuni.2015.05.016 .","journal-title":"Immunity"},{"key":"1414_CR39","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1056\/NEJMra1011165","volume":"365","author":"GL Semenza","year":"2011","unstructured":"Semenza GL. Oxygen sensing, homeostasis, and disease. N Engl J Med. 2011;365:537\u201347. https:\/\/doi.org\/10.1056\/NEJMra1011165 .","journal-title":"N Engl J Med"},{"key":"1414_CR40","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","volume":"369","author":"JM Maris","year":"2007","unstructured":"Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet. 2007;369:2106\u201320. https:\/\/doi.org\/10.1016\/S0140-6736(07)60983-0 .","journal-title":"Lancet"},{"key":"1414_CR41","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.1158\/1078-0432.CCR-08-0576","volume":"14","author":"M Skrzypski","year":"2008","unstructured":"Skrzypski M, et al. Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung. Clin Cancer Res. 2008;14:4794\u20139. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-0576 .","journal-title":"Clin Cancer Res"},{"key":"1414_CR42","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/hep.23098","volume":"50","author":"U Rabenhorst","year":"2009","unstructured":"Rabenhorst U, et al. Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth. Hepatology. 2009;50:1121\u20139. https:\/\/doi.org\/10.1002\/hep.23098 .","journal-title":"Hepatology"},{"key":"1414_CR43","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/hep.27218","volume":"60","author":"M Malz","year":"2014","unstructured":"Malz M, et al. Overexpression of far upstream element (FUSE) binding protein (FBP)-interacting repressor (FIR) supports growth of hepatocellular carcinoma. Hepatology. 2014;60:1241\u201350. https:\/\/doi.org\/10.1002\/hep.27218 .","journal-title":"Hepatology"},{"key":"1414_CR44","doi-asserted-by":"publisher","first-page":"9007","DOI":"10.1038\/sj.onc.1207261","volume":"22","author":"JA Nilsson","year":"2003","unstructured":"Nilsson JA, Cleveland JL. Myc pathways provoking cell suicide and cancer. Oncogene. 2003;22:9007\u201321. https:\/\/doi.org\/10.1038\/sj.onc.1207261 .","journal-title":"Oncogene"},{"key":"1414_CR45","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1158\/1078-0432.CCR-12-0977","volume":"18","author":"DM Miller","year":"2012","unstructured":"Miller DM, Thomas SD, Islam A. Muench, D. & Sedoris, K. c-Myc and cancer metabolism. Clin Cancer Res. 2012;18:5546\u201353. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0977 .","journal-title":"Clin Cancer Res"},{"key":"1414_CR46","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1158\/1078-0432.CCR-15-2296","volume":"22","author":"ZY Xu-Monette","year":"2016","unstructured":"Xu-Monette ZY, et al. Clinical and biologic significance of MYC genetic mutations in De novo diffuse large B-cell lymphoma. Clin Cancer Res. 2016;22:3593\u2013605. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2296 .","journal-title":"Clin Cancer Res"},{"key":"1414_CR47","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1158\/1541-7786.MCR-13-0536","volume":"12","author":"H Beltran","year":"2014","unstructured":"Beltran H. The N-myc oncogene: maximizing its targets, regulation, and therapeutic potential. Mol Cancer Res. 2014;12:815\u201322. https:\/\/doi.org\/10.1158\/1541-7786.MCR-13-0536 .","journal-title":"Mol Cancer Res"},{"key":"1414_CR48","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/sj.onc.1209862","volume":"26","author":"C Chao","year":"2007","unstructured":"Chao C, et al. Constitutively active CCK2 receptor splice variant increases Src-dependent HIF-1 alpha expression and tumor growth. Oncogene. 2007;26:1013\u20139. https:\/\/doi.org\/10.1038\/sj.onc.1209862 .","journal-title":"Oncogene"},{"key":"1414_CR49","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1158\/2159-8290.CD-13-0118","volume":"3","author":"TS Eisinger-Mathason","year":"2013","unstructured":"Eisinger-Mathason TS, et al. Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis. Cancer Discov. 2013;3:1190\u2013205. https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0118 .","journal-title":"Cancer Discov"},{"key":"1414_CR50","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1158\/0008-5472.CAN-05-2738","volume":"66","author":"S Amir","year":"2006","unstructured":"Amir S, Wang R, Matzkin H, Simons JW, Mabjeesh NJ. MSF-A interacts with hypoxia-inducible factor-1alpha and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis. Cancer Res. 2006;66:856\u201366. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-2738 .","journal-title":"Cancer Res"},{"key":"1414_CR51","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1038\/ncomms5514","volume":"5","author":"R Requejo-Aguilar","year":"2014","unstructured":"Requejo-Aguilar R, et al. PINK1 deficiency sustains cell proliferation by reprogramming glucose metabolism through HIF1. Nat Commun. 2014;5:4514. https:\/\/doi.org\/10.1038\/ncomms5514 .","journal-title":"Nat Commun"},{"key":"1414_CR52","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","volume":"7","author":"MA Selak","year":"2005","unstructured":"Selak MA, et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell. 2005;7:77\u201385. https:\/\/doi.org\/10.1016\/j.ccr.2004.11.022 .","journal-title":"Cancer Cell"},{"key":"1414_CR53","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1126\/science.1210557","volume":"333","author":"C Bettegowda","year":"2011","unstructured":"Bettegowda C, et al. Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science. 2011;333:1453\u20135. https:\/\/doi.org\/10.1126\/science.1210557 .","journal-title":"Science"},{"key":"1414_CR54","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2217\/cns.15.32","volume":"4","author":"DP Cahill","year":"2015","unstructured":"Cahill DP, Louis DN, Cairncross JG. Molecular background of oligodendroglioma: 1p\/19q, IDH, TERT, CIC and FUBP1. CNS Oncol. 2015;4:287\u201394. https:\/\/doi.org\/10.2217\/cns.15.32 .","journal-title":"CNS Oncol"},{"key":"1414_CR55","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/hep.28357","volume":"63","author":"J Samarin","year":"2016","unstructured":"Samarin J, et al. PI3K\/AKT\/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells. Hepatology. 2016;63:813\u201326. https:\/\/doi.org\/10.1002\/hep.28357 .","journal-title":"Hepatology"},{"key":"1414_CR56","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/2052-8426-2-32","volume":"2","author":"MA Westhoff","year":"2014","unstructured":"Westhoff MA, et al. A critical evaluation of PI3K inhibition in glioblastoma and neuroblastoma therapy. Mol Cell Ther. 2014;2:32. https:\/\/doi.org\/10.1186\/2052-8426-2-32 .","journal-title":"Mol Cell Ther"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1414-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-019-1414-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1414-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T04:19:44Z","timestamp":1664338784000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-019-1414-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,11]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1414"],"URL":"https:\/\/doi.org\/10.1186\/s13046-019-1414-6","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,11]]},"assertion":[{"value":"25 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"400"}}